Jacob M. Chacko
2022
In 2022, Jacob M. Chacko earned a total compensation of $4.4M as President and Chief Executive Officer at Oric Pharmaceuticals, a 37% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $336,110 |
|---|---|
| Option Awards | $2,970,009 |
| Salary | $572,103 |
| Stock Awards | $474,000 |
| Other | $13,108 |
| Total | $4,365,330 |
Chacko received $3M in option awards, accounting for 68% of the total pay in 2022.
Chacko also received $336.1K in non-equity incentive plan, $572.1K in salary, $474K in stock awards and $13.1K in other compensation.
Rankings
In 2022, Jacob M. Chacko's compensation ranked 767th out of 5,756 executives tracked by ExecPay. In other words, Chacko earned more than 86.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 767 out of 5,756 | 87th |
Division Manufacturing | 345 out of 3,133 | 89th |
Major group Chemicals And Allied Products | 113 out of 1,419 | 92nd |
Industry group Drugs | 100 out of 1,320 | 92nd |
Industry Pharmaceutical Preparations | 73 out of 966 | 92nd |
Source: SEC filing on April 26, 2023.
Chacko's colleagues
We found two more compensation records of executives who worked with Jacob M. Chacko at Oric Pharmaceuticals in 2022.
News
Oric Pharmaceuticals CEO Jacob Chacko's 2023 pay falls 28% to $3.2M
April 24, 2024
Oric Pharmaceuticals CEO Jacob Chacko's 2022 pay falls 37% to $4.4M
April 26, 2023
Oric Pharmaceuticals CEO Jacob Chacko's 2021 pay rises 19% to $7M
April 27, 2022
Oric Pharmaceuticals CEO Jacob Chacko's 2020 pay jumps 774% to $5.9M
April 26, 2021